Welcome to Evently

Lorem ipsum proin gravida nibh vel veali quetean sollic lorem quis bibendum nibh vel velit.

Evently

Stay Connected & Follow us

Simply enter your keyword and we will help you find what you need.

What are you looking for?

Image Alt
  /  2019 Agenda

2019 Agenda

Over the last twenty-five years, academic research has been one of the major driving forces behind the spectacular development of gene therapy for rare or acquired diseases.
Due to the success of recent clinical trials of the last generations of gene therapy products to treat rare genetic diseases and to favorable orphan drug legislation in both Europe and the United States, the biotechnology and pharmaceutical industry is now heavily investing in the field, giving hope to become standard  clinical practice.
The Gene Therapy Area of Major Interest (DIM Gene Therapy) launches the first edition of Gene Therapy for Rare Monogenic Diseases, an international scientific symposium dedicated to recent knowledge and progress in the field to ensure faster and more efficacious development of therapies for diseases with high unmet medical needs. With 200 intended key actors, this two-day event is the unique opportunity to discover the latest gene therapy trends and to see emerge high-potential collaborations.

THE PROGRAM INCLUDES

  • Conferences with international high-level speakers from Europe and the US, mainly focused on clinical gene therapy
  • Presentations of research activities and major achievements from the Gene
    Therapy Area of Major Interest initiative research teams in the larger context of the recent progress in the field
  • Posters on the latest gene therapy trends and technologies

WHY PARTICIPATE ?

  • Meet international key actors in the field of gene therapy
  • Discover the latest trends in the field
  • Get an overview of the most innovative ongoing research projects led by Paris Region academic groups under the Gene Therapy Area of Major Interest
    initiative
Right Parallax Background Element
Day 1 – Feb. 7th
1:00 pm – 1:30 pm
1:00 pm
1:30 pm

WELCOME

1:30 pm – 2:00 pm
1:30 pm
2:00 pm

Introduction of the journey

by Stanislas LYONNET, Director of the Imagine Institute, and Arnold MUNNICH, President of the Imagine Institute and Faten HIDRI, Vice president of the Isle-of-France Region, Minister of Higher Education and Research
2:00 pm – 3:30 pm
2:00 pm
3:30 pm

Conferences on Lysosomal Storage and Neuromuscular Diseases

Presentations by Alessandra BIFFI (Harvard Medical School), Kevin FLANIGAN (Nationwide Children’s Hospital) and Fulvio MAVILIO (University of Modena and Reggio Emilia)
3:30 pm – 4:00 pm
3:30 pm
4:00 pm

COFFEE BREAK & POSTER SESSION

4:00 pm – 5:00 pm
4:00 pm
5:00 pm

DIM Gene Therapy presentations

Discover ongoing research projects in the field of deafness, retinal dystrophies and corneal stem cell deficiencies
5:00 pm – 7:00 pm
5:00 pm
7:00 pm

COCKTAIL RECEPTION

Day 1 – Feb. 7th

  • WELCOME
    1:00 pm – 1:30 pm
  • Introduction of the journey
    1:30 pm – 2:00 pm
  • Conferences on Lysosomal Storage and Neuromuscular Diseases
    2:00 pm – 3:30 pm
  • COFFEE BREAK & POSTER SESSION
    3:30 pm – 4:00 pm
  • DIM Gene Therapy presentations
    4:00 pm – 5:00 pm
  • COCKTAIL RECEPTION
    5:00 pm – 7:00 pm
Left Parallax Background Element
Left Parallax Background Element
Day 2 – Feb. 8th
09:00 – 10:45
09:00
10:45

Conferences on Haemophilia and AAV immunity

Presentations by Amit NATHWANI (University College London), Virginia HAURIGOT (Spark Therapeutics), Olivier DANOS (REGENXBIO) and Cesar TRIGUEROS (Viralgen)
10:45 – 11:15
10:45
11:15

COFFEE BREAK

Poster session and workshop
11:15 – 12:35
11:15
12:35

DIM Gene Therapy presentations

Discover ongoing research projects in the field of gene editing, sickle-cell disease, and CAR-Treg
12:35 – 14:00
12:35
14:00

LUNCH BREAK

14:00 – 14:45
14:00
14:45

The Prospect of Gene Editing

Keynote address on gene editing for hemoglobinopathies by Matthew PORTEUS (Stanford University)
14:45 – 15:45
14:45
15:45

Conferences on Haematological diseases

Presentations by Giuliana FERRARI (San Raffaele-TIGET) and Juan BUEREN (CIEMAT/CIBERER)
15:45 – 16:15
15:45
16:15

COFFEE BREAK & POSTER SESSION

16:15 – 16:45
16:15
16:45

Conferences on Haematological diseases

Presentations by Jean-Antoine RIBEIL (Bluebird Bio)
16:45 – 17:30
17:00
17:30

Final lecture and conclusion

By Marina CAVAZZANA, Coordinator of the DIM Gene Therapy
17:30
17:30
17:30

END OF THE EVENT

Day 2 – Feb. 8th

  • Conferences on Haemophilia and AAV immunity
    09:00 – 11:00
  • COFFEE BREAK & POSTER SESSION
    10:45 – 11:15
  • Conferences on Haematological diseases
    11:15 – 12:35
  • LUNCH BREAK
    12:35 – 14:00
  • The Prospect of Gene Editing
    14:00 – 14:45
  • DIM Gene Therapy presentations
    14:45 – 15:45
  • COFFEE BREAK & POSTER SESSION
    15:45 – 16:15
  • DIM Gene Therapy presentations
    16:15 – 16:45
  • Final lecture and conclusion
    16:45 – 17:30
Left Parallax Background Element